Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-8,644
Closed -$1.12M 229
2018
Q4
$1.12M Sell
8,644
-10,820
-56% -$444K 0.11% 182
2018
Q3
$2.29M Sell
19,464
-37,508
-66% -$1.52M 0.17% 154
2018
Q2
$2.29M Buy
56,972
+7,672
+16% +$295K 0.17% 149
2018
Q1
$1.86M Sell
49,300
-8,628
-15% -$349K 0.15% 169
2017
Q4
$2.52M Sell
57,928
-2,656
-4% -$106K 0.18% 151
2017
Q3
$2.3M Buy
60,584
+10,039
+20% +$405K 0.17% 157
2017
Q2
$2.33M Buy
50,545
+33,221
+192% +$1.47M 0.17% 140
2017
Q1
$1.82M Buy
17,324
+1,876
+12% +$76.5K 0.12% 174
2016
Q4
$1.63M Sell
15,448
-20,741
-57% -$800K 0.1% 192
2016
Q3
$1.41M Sell
36,189
-5,277
-13% -$199K 0.1% 199
2016
Q2
$1.51M Buy
+41,466
New +$1.44M 0.09% 205
2013
Q4
Sell
-166,414
Closed -$3.44M 311
2013
Q3
$3.44M Sell
166,414
-481,762
-74% -$10.3M 0.14% 184
2013
Q2
$12.5M Buy
+648,176
New +$13.5M 0.51% 63

Other funds holding HOLX

Penn Capital Management's HOLX Position: Q1 2019 in Review

Penn Capital Management sold out of Hologic (HOLX) in Q1 2019, closing a stake of 8,644 shares — an estimated $1.12M sold.

Penn Capital Management first reported a position in HOLX in Q2 2013 and held it in 13 quarters. The position peaked at $12.5M in Q2 2013. 467 funds tracked by Wall St. Rank hold HOLX as of Q1 2019.

  • Penn Capital Management reported no remaining Hologic position as of Q1 2019 after selling out during the quarter.
  • Penn Capital Management sold 8,644 Hologic shares in Q1 2019, an estimated $1.12M.
  • Penn Capital Management first reported a position in Hologic in Q2 2013 and held it in 13 quarters.
  • Penn Capital Management's Hologic position peaked at $12.5M in Q2 2013.
  • 467 funds tracked by Wall St. Rank held Hologic as of Q1 2019.

Based on Penn Capital Management's 13F filing for Q1 2019, filed 6 May 2019.